Harvey M. Golomb to Hodgkin Disease
This is a "connection" page, showing publications Harvey M. Golomb has written about Hodgkin Disease.
Connection Strength
0.625
-
Management of early-stage Hodgkin's disease: a continuing evolution. Semin Oncol. 1998 Aug; 25(4):476-82.
Score: 0.149
-
The staging of Hodgkin's disease. Hematol Oncol Clin North Am. 1989 Jun; 3(2):237-51.
Score: 0.079
-
Hairy-cell leukemia associated with Hodgkin's disease: a case report. Am J Hematol. 1985 Apr; 18(4):413-9.
Score: 0.059
-
Treatment of stage IIIA Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):827-34.
Score: 0.048
-
Diagnosis, staging, and treatment of the malignant lymphomas. Compr Ther. 1980 Jul; 6(7):48-56.
Score: 0.042
-
Importance of substaging of stage III Hodgkin's disease. Semin Oncol. 1980 Jun; 7(2):136-43.
Score: 0.042
-
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease. J Clin Oncol. 1991 May; 9(5):754-61.
Score: 0.022
-
Is pelvic irradiation necessary in stage III1A Hodgkin's disease? Int J Radiat Oncol Biol Phys. 1990 Sep; 19(3):715-9.
Score: 0.021
-
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):761-6.
Score: 0.020
-
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol. 1988 Jun; 6(6):1047-52.
Score: 0.018
-
Perspective on staging approaches in the malignant lymphomas. Surg Gynecol Obstet. 1986 Aug; 163(2):193-201.
Score: 0.016
-
Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980). J Clin Oncol. 1985 Jun; 3(6):758-68.
Score: 0.015
-
Mitoxantrone in malignant lymphomas. Cancer Treat Rev. 1983 Dec; 10 Suppl B:69-72.
Score: 0.013
-
Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative study. Cancer Treat Rep. 1982 Apr; 66(4):733-41.
Score: 0.012
-
Late relapses in Hodgkin disease. Am J Hematol. 1981; 10(1):31-6.
Score: 0.011
-
Anatomic substages of stage III-A Hodgkin's disease. A collaborative study. Ann Intern Med. 1980 Feb; 92(2 Pt 1):159-65.
Score: 0.010
-
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
Score: 0.010
-
Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42.
Score: 0.009
-
Sepsis in treated Hodgkin's disease. Am J Med. 1978 May; 64(5):914-5.
Score: 0.009
-
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. Blood. 1977 Jun; 49(6):883-93.
Score: 0.009
-
Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant. 1990 Feb; 5(2):129-33.
Score: 0.005
-
Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981 Oct; 58(4):759-67.
Score: 0.003